Drug Trial Radar · NCT01928771
Efficacy and Safety Study of Benralizumab Added to High-dose Inhaled Corticosteroid Plus LABA in Patients With Uncontrolled Asthma
Last checked: Nov 20, 2026Latest source record: May 3, 2017 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
2,681
Actual
Start
Sep 19, 2013
Primary completion
Apr 5, 2016
Study completion Apr 5, 2016
Sponsor
- Lead sponsor
- AstraZenecaAstraZeneca (AZN)
- Sponsor type
- Industry
- First posted
- Aug 27, 2013
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 12 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to determine whether Benralizumab reduces the number of asthma exacerbations in patients who remain uncontrolled on high doses of ICS-LABA.
Conditions
- Asthma
Interventions
BenralizumabBiological
Benralizumab subcutaneously on study week 0 until study week 44 inclusive.
PlaceboBiological
Placebo subcutaneously on study week 0 until study week 44 inclusive.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Annual Asthma Exacerbation Rate in Adult and Adolescent Patients With Uncontrolled Asthma for Eosinophils >=300/uLTime frame: Immediately following the first administration of study drug through Study Week 48.
Locations
275 sites in 17 countries. Site status is shown where the registry gives one.
Research Site
Foley, Alabama
Research Site
Huntsville, Alabama
Research Site
Mobile, Alabama
Research Site
Scottsboro, Alabama
Research Site
Sheffield, Alabama
Research Site
Phoenix, Arizona
Research Site
Tucson, Arizona
Research Site
Bakersfield, California
Research Site
Beverly Hills, California
Research Site
Costa Mesa, California
Research Site
Huntington Beach, California
Research Site
Huntington Park, California
Research Site
Los Angles, California
Research Site
Newport Beach, California
Research Site
Orange, California
Research Site
Riverside, California
Research Site
San Jose, California
Research Site
Santa Ana, California
Research Site
Hartford, Connecticut
Research Site
New Haven, Connecticut
Research Site
Brandon, Florida
Research Site
Clearwater, Florida
Research Site
Cutler Bay, Florida
Research Site
DeLand, Florida
Research Site
Gainesville, Florida
Research Site
Hialeah, Florida
Research Site
Hollywood, Florida
Research Site
Homestead, Florida
Research Site
Jackonsville, Florida
Research Site
Lynn Haven, Florida
Research Site
Miami, Florida
Research Site
Orlando, Florida
Research Site
Pembroke Pines, Florida
Research Site
Port Charlotte, Florida
Research Site
Sebring, Florida
Research Site
St. Petersburg, Florida
Research Site
Tampa, Florida
Research Site
Vero Beach, Florida
Research Site
Winter Park, Florida
Research Site
Albany, Georgia
Showing 40 of 275 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.